Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +56.03%
#3 Glidr Glidr +38.25%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.97%
#6 Humanity Humanity +20.80%
#7 Tutorial Tutorial +17.00%
#8 Enso Enso +15.98%
#9 Velvet Velvet +15.00%
#10 Huma Finance Huma Finance +13.59%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Rang in Aktien #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Aktienkurs
$0.069
Zuletzt synchronisiert: 2024-07-22
Marktkapitalisierung
$2.06M
Veränderung (1 Tag)
-1.43%
Veränderung (1 Jahr)
0.00%
Land
US
Handel DermTech, Inc. (DMTK)

Kategorie

Healthcare
P/S-Verhältnis für DermTech, Inc. (DMTK)
P/S-Verhältnis zum August 2026 TTM: 0.21
Laut den neuesten Finanzberichten und dem Aktienkurs von DermTech, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0.21. Am Ende des Jahres 2022 lag das P/S-Verhältnis bei 3.66.
P/S-Verlauf für DermTech, Inc. von 2016 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
2026 (TTM) 0.21 -93.93%
2023 3.54 -3.27%
2022 3.66 -90.50%
2021 38.55 -58.81%
2020 93.59 262.47%
2019 25.82 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
4.72 2,095.53%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
5.67 2,537.74%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
16.40 7,529.83%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
9.55 4,341.69%
US